Allarity Therapeutics Exchanges $3 Million of Debt for $3.15 Million of Preferred Stock
Allarity Therapeutics (ALLR) converted $3M debt to Streeterville Capital into $3.15M of preferred stock. The deal, closed Nov. 16, 2026, includes a side letter requiring 33% of future ATM sales proceeds to go to Streeterville. No cash changed hands.
